Epigenomics AG (LON:0QXH)
London flag London · Delayed Price · Currency is GBP · Price in EUR
1.110
+0.209 (23.24%)
At close: Dec 23, 2024

Epigenomics AG Revenue

Epigenomics AG had revenue of 136.23K EUR in the twelve months ending June 30, 2024, down -69.52% year-over-year. In the year 2023, Epigenomics AG had annual revenue of 339.23K, down -62.27%.

Revenue (ttm)
136.23K EUR
Revenue Growth
-69.52%
P/S Ratio
n/a
Revenue / Employee
22.70K EUR
Employees
6
Market Cap
810.37K GBP

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023339.23K-559.77K-62.27%
Dec 31, 2022899.00K-5.30M-85.51%
Dec 31, 20216.20M5.36M636.70%
Dec 31, 2020842.00K-283.00K-25.16%
Dec 31, 20191.13M-408.00K-26.61%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AstraZeneca 43.19B
Shell 227.10B
HSBC Holdings 48.93B
Unilever 50.25B
Rio Tinto Group 42.86B
RELX PLC 9.43B
BP p.l.c. 149.68B
British American Tobacco p.l.c. 25.87B
Revenue Rankings